@DrChoueiri presents first biomarker work from #keynote564 — ctDNA positive group only n=60 treated but poor prognosis begs question who to escalate?? And who in neg-neg group may we de-escalate treatment? @asco #ASCO26 @oncoalert @urotoday @utswcancer